Waiting.
It sounds like a passive verb, something you do in a dentist’s chair while thumbing through a year-old magazine. In Gaza, for a woman who has just felt a hard, unyielding knot beneath her skin, waiting is not passive at all. It is a slow, cellular negotiation with time. Every week that passes without a scan, a biopsy, a targeted drug, or a beam of radiation gives microscopic rogue cells another chance to divide, migrate, and claim territory inside a body that is already exhausted just trying to find clean water and a safe place to sleep. Learn more on a related issue: this related article.
Oncology is built on urgency. When breast cancer is caught early and treated on schedule with modern diagnostics, surgery, chemotherapy, and radiotherapy, five-year survival rates can climb above eighty percent. In Gaza, that biological clock runs against a wall of shattered infrastructure, scarce medicines, and bureaucratic bottlenecks. When patients and doctors say that the longer they wait, the worse it gets, they are stating a brutal medical reality.
When Early Detection Goes Dark
To understand what happens inside Gaza’s clinics, it helps to use a simple analogy. (This comparison is a metaphor to illustrate how medical screening works.) Think of a cancer screening program like smoke detectors in a crowded building. Before the war, Gaza had roughly fifteen mammography machines—smoke detectors stationed along the corridors, catching trouble while a spark was still small enough to stamp out with a cup of water. By late 2026, only about three mammography machines remained across the Strip, alongside severe shortages of MRI, CT, and nuclear imaging. More reporting by Mayo Clinic explores similar perspectives on this issue.
When smoke detectors fail, fires do not stop starting. They simply go unnoticed until smoke curls under the door.
Health authorities in Gaza have warned that the collapse of screening and early diagnosis services is masking hundreds of breast cancer cases. If a clinic lacks working imaging equipment, reagents for pathology, or reliable appointments—with waits sometimes stretching past three months—women who might once have been diagnosed at Stage I or Stage II arrive later, when symptoms are unmistakable and treatment options are narrower.
(The following vignette is a composite, hypothetical scenario constructed from documented patient experiences in Gaza to illustrate the emotional and practical sequence of delayed care.)
Picture Nadia, a forty-two-year-old mother of three living in a crowded shelter after losing her home. One evening, while washing clothes by hand because electricity is unreliable, she notices a firm lump near her collarbone and armpit. She tries not to panic, though her chest tightens every time she lies down. Reaching a clinic that can actually evaluate her takes weeks of navigating disrupted transport, damaged facilities, and long queues. By the time a doctor confirms breast cancer, she is not just fighting a tumor. She is fighting a calendar that has already turned against her.
Inside a Strained Oncology Ward
Even after a diagnosis is confirmed, survival depends on what sits on the pharmacy shelf and what equipment hums in the treatment rooms. Across Gaza, only a handful of hospitals can offer oncology services at all, and medical directors have described severe shortages of essential chemotherapy drugs and basic supportive supplies.
Imagine trying to bake bread when half your ingredients are missing and the oven cannot reach the right temperature. (Again, this is a metaphor for how treatment compromises work in practice.) Oncologists in Gaza have had to modify or postpone treatment regimens based on which medications happen to be on hand and how each patient’s body is holding up. In some instances, physicians have even been forced to use expired chemotherapy agents when no alternatives existed—a desperate measure born of scarcity rather than choice.
Then there is radiotherapy, a cornerstone of breast cancer care used after surgery or chemotherapy to lower the risk of recurrence and treat advanced disease. Radiotherapy is unavailable inside the Gaza Strip. A patient can endure grueling cycles of chemotherapy or undergo a mastectomy, only to hit a dead end when the next required step simply does not exist locally.
Recovery outside the hospital brings its own quiet torment. Healing tissue needs nourishment, rest, and basic supplements, yet patients frequently report struggling to afford vitamins in private pharmacies when hospital stocks run dry. Carrying water, managing household chores without gas or steady power, and living amid displacement turn everyday recovery into physical strain. A woman recovering from breast surgery does not get to rest in a quiet room; she wakes up to noise, crowding, and constant worry about whether her next dose will even be there.
The Border Between Diagnosis and Survival
When radiation or specialized oncology care cannot be delivered in Gaza, leaving for treatment abroad becomes the lifeline. Yet medical evacuation has long been a maze of approvals, referrals, and delays.
Around twenty-one thousand patients have been waiting to leave Gaza for medical care, while human rights monitors have documented hundreds of cancer patients among those who died while waiting for exit permits and evacuation slots. A doctor can write a referral stating that a patient needs radiotherapy by February, and April can arrive—or pass—without a travel approval coming through.
For a reader sitting comfortably far from any border crossing, it is easy to view evacuation numbers as abstract policy statistics. It is harder—and more honest—to admit how confounding and frightening this reality is when you try to imagine being inside it. You do not control the border. You do not control the supply chain. You only control whether you wake up tomorrow, check your phone, and pray your name is finally on a list.
Sometimes, when a patient finally makes it out to a hospital in Egypt or another destination, the journey comes too late. Months lost to screening delays, interrupted regimens, or waiting for a stamp mean the disease has progressed beyond what even skilled specialists abroad can easily reverse.
Why the Body Keeps Score Beyond the Tumor
Cancer rarely respects neat boundaries between medicine, psychology, and daily survival. A breast cancer diagnosis already shakes a person’s sense of identity and security; losing a breast compounds that grief, especially when stigma, exhaustion, and displacement press in from every side.
Clinical studies examining cancer care in Gaza before and during war highlight how intertwined these pressures are. Long before the latest escalation, patients faced fragmented pathways, financial strain, and permit hurdles. War and siege magnified every single one of those fractures—turning routine follow-ups into risky journeys and turning basic nutrition into a daily negotiation.
It is worth pausing on that distinction. Breast cancer is not a single event that ends when a lump is removed. It is a marathon of scans, infusions, side effects, blood counts, and follow-up visits. When that marathon is interrupted again and again, fear becomes a constant companion. Even patients who manage to start treatment live with the dread that a supply shortage, a clinic closure, or a delayed referral will pull the rug out from under their progress.
For those of us watching from afar, the temptation is to look away when the story feels too heavy or too complex to fix with a single click. That instinct is human. Being honest about how overwhelming a prolonged humanitarian and medical crisis feels is better than pretending it is simple. Still, looking away does not change what happens in an examination room when a mammogram machine is broken or a chemotherapy vial is empty.
Every delayed scan in Gaza carries a human face behind it—a mother, a daughter, a sister, a neighbor—counting hours in a place where time is the scarcest medicine of all.